Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08HKT
|
||||
Former ID |
DIB008616
|
||||
Drug Name |
BEMORADAN
|
||||
Synonyms |
Orf-22867; RWJ-22867; Bemoradan < Rec INN >; Rac-7-(1,4,5,6-Tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-2H-1,4-benzoxazin-3(4H)-one; Rac-5-Methyl-6-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)-2,3,4,5-tetrahydropyridazin-3-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Heart failure [ICD9: 428; ICD10:I50] | Phase 2 | [526254] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H13N3O3
|
||||
Canonical SMILES |
CC1CC(=O)NN=C1c2ccc3NC(=O)COc3c2
|
||||
InChI |
1S/C13H13N3O3/c1-7-4-11(17)15-16-13(7)8-2-3-9-10(5-8)19-6-12(18)14-9/h2-3,5,7H,4,6H2,1H3,(H,14,18)(H,15,17)
|
||||
InChIKey |
XZPGINPFWXLYNW-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 112018-01-6
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CGMP-inhibited 3',5'-cyclic phosphodiesterase A | Target Info | Inhibitor | [551871] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.